Research Article

Feasibility of Imaging Esophageal Cancer with Labeled Somatostatin Analogue

Figure 2

99mTc-depreotide uptake measured 2 hours after injection in patients with esophageal cancer and Barrett’s esophagus.
279345.fig.002